Apogee Therapeutics Inc.

APGE | NASDAQ

Price Alert Chart Builder DCF Calculator

$135.07

$0 (0.00%)

Sep 4, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $8.36B

Enterprise Value $7.39B

Beta 0.34

Average Volume 2.59M

Shares Outstanding (Diluted) 75.44M

Shares Change YoY 29.12%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US03770N1019

Price Performance

Price Change 1M 0.4%

Price Change 3M 52.7%

Price Change 6M 97.2%

Price Change YTD 78.2%

Price Change 1Y 266.4%

Price Change 3Y 547.2%

Price Change 5Y 536.2%

1M CAGR (ann.) 0.7%

1Y CAGR (ann.) 256.8%

5Y CAGR (ann.) N/A

All-Time CAGR 80.3%

Valuation

PE Ratio -31.12

Forward PE N/A

PEG Ratio 6.57

Forward PEG -1.06

PS Ratio N/A

Forward PS 1,504.40

PB Ratio 7.00

P/FCF Ratio -34.26

P/Adj. FCF Ratio -27.71

P/OCF Ratio -41.82

EV/Sales N/A

EV/EBIT -25.27

EV/EBITDA -25.38

EV/FCF -30.30

Earnings Yield -3.2%

FCF Yield -2.9%

Adj. FCF Yield -3.6%

Financial Health

Net Cash $971.93M

Total Debt $6.83M

Cash & Short-Term Investments $971.93M

Total Assets $1.34B

Current Ratio 26.44

Quick Ratio 26.44

Debt / Equity Ratio 0.01

Debt / EBITDA -0.02

Debt / FCF -0.03

OCF / Debt -35.69

Interest Coverage -207.66

Altman Z-Score 34.89

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -23.6%

Returns

Return on Assets -22.0%

Return on Equity -29.9%

Return on Invested Capital -25.2%

Return on Capital Employed -25.3%

Return on Tangible Assets -22.0%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -28.7%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -34.3%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 14

EPS Growth Next 3Y -18.0%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$1.14

EPS Growth Est (next Q) 2.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $130.92

Price Target Upside -3.1%

Cash Flow

Operating Cash Flow $-243.89M

Free Cash Flow $-243.96M

Adj. Free Cash Flow $-301.58M

FCF Per Share -$3.23

OCF Per Share -$3.23

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-408K

Operating Income $-328.11M

EBITDA $-291.3M

Net Income $-294.37M

EPS (Diluted) -$4.34

Revenue / Employee N/A

Profit / Employee $-1.13M

Employees 261